放射性医薬品の世界市場:放射性同位体別(テクネチウム-99、ガリウム-67、ヨウ素-123、18F、ルビジウム-82、イットリウム-90、ルテチウム-177)、由来別(原子炉、サイクロトロン)、用途別(心臓病学、消化器病学、腫瘍学、腎臓学、神経学、免疫学、その他)、エンドユーザー別(病院、外来手術センター、診断センター、その他)、地域別予測

【英語タイトル】Global Radiopharmaceuticals Market Size study, by Radioisotope (Technetium-99, Gallium-67, Iodine-123, 18F, Rubidium-82, Yttrium-90, Lutetium-177), by Source (Nuclear Reactors, Cyclotrons), by Application (Cardiology, Gastroenterology, Oncology, Nephrology, Neurology, Immunology, Others), by End-User (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Others) and Regional Forecasts 2019-2026

Bizwit Research & Consultingが出版した調査資料(BZW9JN065)・商品コード:BZW9JN065
・発行会社(調査会社):Bizwit Research & Consulting
・発行日:2019年5月15日
・ページ数:約150
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル、日本、アメリカ、カナダ、イギリス、ドイツ、フランス、中国、インド、ブラジル、メキシコ
・産業分野:医療・バイオ
◆販売価格オプション(消費税別)
Single User(1名様閲覧用、印刷不可)USD3,950 ⇒換算¥426,600見積依頼/購入/質問フォーム
Enterprisewide(同一法人内共有可)USD5,550 ⇒換算¥599,400見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本資料は、放射性医薬品の世界市場について調べ、放射性医薬品の世界規模、市場動向、市場環境、放射性同位体別(テクネチウム-99、ガリウム-67、ヨウ素-123、18F、ルビジウム-82、イットリウム-90、ルテチウム-177)分析、由来別(原子炉、サイクロトロン)分析、用途別(心臓病学、消化器病学、腫瘍学、腎臓学、神経学、免疫学、その他)分析、エンドユーザー別(病院、外来手術センター、診断センター、その他)分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、日本市場規模、中国市場規模、関連企業情報などをまとめた調査レポートです。

・イントロダクション
・エグゼクティブサマリー
・放射性医薬品の世界市場概要
・放射性医薬品の世界市場環境
・放射性医薬品の世界市場動向
・放射性医薬品の世界市場規模
・放射性医薬品の世界市場規模:放射性同位体別(テクネチウム-99、ガリウム-67、ヨウ素-123、18F、ルビジウム-82、イットリウム-90、ルテチウム-177)
・放射性医薬品の世界市場規模:由来別(原子炉、サイクロトロン)
・放射性医薬品の世界市場規模:用途別(心臓病学、消化器病学、腫瘍学、腎臓学、神経学、免疫学、その他)
・放射性医薬品の世界市場規模:エンドユーザー別(病院、外来手術センター、診断センター、その他)
・放射性医薬品の世界市場:地域別市場規模・分析
・放射性医薬品の北米市場規模・予測
・放射性医薬品のアメリカ市場規模・予測
・放射性医薬品のヨーロッパ市場規模・予測
・放射性医薬品のアジア市場規模・予測
・放射性医薬品の日本市場規模・予測
・放射性医薬品の中国市場規模・予測
・関連企業情報
【レポートの概要】

Global Radiopharmaceuticals Market valued approximately USD 5.72 billion in 2018 is anticipated to grow with a healthy growth rate of more than 5.60% over the forecast period 2019-2026. The Radiopharmaceuticals Market is continuously growing in the global scenario at significant pace. Radiopharmaceuticals are a group of pharmaceuticals drug which have radioactivity. It can be used as diagnostic and therapeutic agent. Radiopharmaceuticals are unique medicinal formulations containing radioisotopes which are used in major clinical area for diagnosis or therapy. The procedures and facilities for the production, use, and storage of radiopharmaceuticals are subject to licensing by national or regional authorities. Increasing incidence of cardiovascular diseases, growing preference for PET and SPET scans, rise in consciousness about positive effects and enhancements in radiotracers are the substantial driving factors of the market during the forecast period. Moreover, increase in use of radiopharmaceuticals in neurological applications are the factors that likely to create numerous opportunity in the near future. However, scarcity of radioisotopes, strict regulatory standards and high cost of the procedure are the factors that limiting the growth of the market during the forecast period.

The regional analysis of Global Radiopharmaceuticals Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share due to presence of excellent research facilities and rising healthcare expenditure in the region. Europe is estimated to grow at stable growth rate in the global Radiopharmaceuticals market over the upcoming years. Further, Asia-Pacific is anticipated to exhibit higher growth rate / CAGR over the forecast period 2019-2026 due to rising demand for PET and SPECT devices and rising patient awareness levels pertaining to cardiovascular diseases and oncology in the region.

The major market player included in this report are:
Advanced Accelerator Applications (AAA)
Bayer AG
Eckert & Ziegler
GE Healthcare
IBA Radiopharma Solutions
Lantheus Holdings Inc.
Mallinckrodt Plc
Nordion Inc.
Positron Corporation
Siemens Healthineers

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Radioisotope:

Technetium-99
Gallium-67
Iodine-123
18F
Rubidium-82
Yttrium-90
Lutetium-177

By Source:

Nuclear Reactors
Cyclotrons

By Application:
Cardiology
Gastroenterology
Oncology
Nephrology
Neurology
Immunology
Others

By End-User:

Hospitals
Ambulatory Surgical Centers
Diagnostic Centers
Others

By Regions:
North America
U.S.
Canada
Europe
UK
Germany
Asia Pacific
China
India
Japan
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2016, 2017
Base year – 2018
Forecast period – 2019 to 2026

Target Audience of the Global Radiopharmaceuticals Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

【レポートの目次】

TABLE OF CONTENTS

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Key Trends
1.3. Global & Segmental Market Estimates & Forecasts, 2016-2026 (USD Billion)
1.3.1. Radiopharmaceuticals Market, by Radioisotope, 2016-2026 (USD Billion)
1.3.2. Radiopharmaceuticals Market, by Source, 2016-2026 (USD Billion)
1.3.3. Radiopharmaceuticals Market, by Application, 2016-2026 (USD Billion)
1.3.4. Radiopharmaceuticals Market, by End-User, 2016-2026 (USD Billion)
1.3.5. Radiopharmaceuticals Market, by Region, 2016-2026 (USD Billion)
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Radiopharmaceuticals Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Radiopharmaceuticals Market Dynamics
3.1. See Saw Analysis
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Radiopharmaceuticals Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Buyers
4.1.2. Bargaining Power of Suppliers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.2. PEST Analysis
4.2.1. Political Scenario
4.2.2. Economic Scenario
4.2.3. Social Scenario
4.2.4. Technological Scenario
4.3. Key Buying Criteria
4.4. Regulatory Framework
4.5. Investment Vs Adoption Scenario
4.6. Analyst Recommendation & Conclusion
Chapter 5. Radiopharmaceuticals Market, by Radioisotope
5.1. Market Snapshot
5.2. Market Performance – Potential Model
5.3. Key Market Players
5.4. Radiopharmaceuticals Market, Sub Segment Analysis
5.4.1. Technetium-99
5.4.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
5.4.2. Gallium-67
5.4.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
5.4.2.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
5.4.3. Iodine-123
5.4.3.1. Market estimates & forecasts, 2016-2026 (USD Billion)
5.4.3.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
5.4.4. 18F
5.4.4.1. Market estimates & forecasts, 2016-2026 (USD Billion)
5.4.4.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
5.4.5. Rubidium-82
5.4.5.1. Market estimates & forecasts, 2016-2026 (USD Billion)
5.4.5.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
5.4.6. Yttrium-90
5.4.6.1. Market estimates & forecasts, 2016-2026 (USD Billion)
5.4.6.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
5.4.7. Lutetium-177
5.4.7.1. Market estimates & forecasts, 2016-2026 (USD Billion)
5.4.7.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
Chapter 6. Radiopharmaceuticals Market, by Source
6.1. Market Snapshot
6.2. Market Performance – Potential Model
6.3. Key Market Players
6.4. Radiopharmaceuticals Market, Sub Segment Analysis
6.4.1. Nuclear Reactors
6.4.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
6.4.1.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
6.4.2. Cyclotrons
6.4.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
6.4.2.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
Chapter 7. Radiopharmaceuticals Market, by Application
7.1. Market Snapshot
7.2. Market Performance – Potential Model
7.3. Key Market Players
7.4. Radiopharmaceuticals Market, Sub Segment Analysis
7.4.1. Cardiology
7.4.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
7.4.1.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.4.2. Gastroenterology
7.4.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
7.4.2.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.4.3. Oncology
7.4.3.1. Market estimates & forecasts, 2016-2026 (USD Billion)
7.4.3.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.4.4. Nephrology
7.4.4.1. Market estimates & forecasts, 2016-2026 (USD Billion)
7.4.4.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.4.5. Neurology
7.4.5.1. Market estimates & forecasts, 2016-2026 (USD Billion)
7.4.5.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.4.6. Immunology
7.4.6.1. Market estimates & forecasts, 2016-2026 (USD Billion)
7.4.6.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.4.7. Others
7.4.7.1. Market estimates & forecasts, 2016-2026 (USD Billion)
7.4.7.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
Chapter 8. Radiopharmaceuticals Market, by End-User
8.1. Market Snapshot
8.2. Market Performance – Potential Model
8.3. Key Market Players
8.4. Radiopharmaceuticals Market, Sub Segment Analysis
8.4.1. Hospitals
8.4.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
8.4.2. Ambulatory Surgical Centers
8.4.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
8.4.2.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.4.3. Diagnostic Centers
8.4.3.1. Market estimates & forecasts, 2016-2026 (USD Billion)
8.4.3.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.4.4. Others
8.4.4.1. Market estimates & forecasts, 2016-2026 (USD Billion)
8.4.4.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
Chapter 9. Radiopharmaceuticals Market, by Regional Analysis
9.1. Radiopharmaceuticals Market, Regional Market Snapshot (2016-2026)
9.2. North America Radiopharmaceuticals Market Snapshot
9.2.1. U.S.
9.2.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
9.2.1.2. Radioisotope breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.2.1.3. Sources breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.2.1.4. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.2.1.5. End-User breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.2.2. Canada
9.2.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
9.2.2.2. Radioisotope breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.2.2.3. Source breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.2.2.4. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.2.2.5. End-User breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.3. Europe Radiopharmaceuticals Market Snapshot
9.3.1. U.K.
9.3.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
9.3.1.2. Radioisotope breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.3.1.3. Source breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.3.1.4. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.3.1.5. End-User breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.3.2. Germany
9.3.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
9.3.2.2. Radioisotope breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.3.2.3. Source breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.3.2.4. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.3.2.5. End-User breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.3.3. Rest of Europe
9.3.3.1. Market estimates & forecasts, 2016-2026 (USD Billion)
9.3.3.2. Radioisotope breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.3.3.3. Source breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.3.3.4. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.3.3.5. End-User breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.4. Asia Radiopharmaceuticals Market Snapshot
9.4.1. China
9.4.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
9.4.1.2. Radioisotope breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.4.1.3. Source breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.4.1.4. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.4.1.5. End-User breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.4.2. India
9.4.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
9.4.2.2. Radioisotope breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.4.2.3. Source breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.4.2.4. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.4.2.5. End-User breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.4.3. Japan
9.4.3.1. Market estimates & forecasts, 2016-2026 (USD Billion)
9.4.3.2. Radioisotope breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.4.3.3. Source breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.4.3.4. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.4.3.5. End-User breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.4.4. Rest of Asia Pacific
9.4.4.1. Market estimates & forecasts, 2016-2026 (USD Billion)
9.4.4.2. Radioisotope breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.4.4.3. Source breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.4.4.4. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.4.4.5. End-User breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.5. Latin America Radiopharmaceuticals Market Snapshot
9.5.1. Brazil
9.5.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
9.5.1.2. Radioisotope breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.5.1.3. Source breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.5.1.4. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.5.1.5. End-User breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.5.2. Mexico
9.5.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
9.5.2.2. Radioisotope breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.5.2.3. Source breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.5.2.4. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.5.2.5. End-User breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.6. Rest of The World
9.6.1. South America
9.6.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
9.6.1.2. Radioisotope breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.6.1.3. Source breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.6.1.4. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.6.1.5. End-User breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.6.2. Middle East and Africa
9.6.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
9.6.2.2. Radioisotope breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.6.2.3. Source breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.6.2.4. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.6.2.5. End-User breakdown estimates & forecasts, 2016-2026 (USD Billion)
Chapter 10. Competitive Intelligence
10.1. Company Market Share (Subject to Data Availability)
10.2. Top Market Strategies
10.3. Company Profiles
10.3.1. Advanced Accelerator Applications (AAA)
10.3.1.1. Overview
10.3.1.2. Financial (Subject to Data Availability)
10.3.1.3. Summary
10.3.1.4. Recent Developments
10.3.2. Bayer AG
10.3.3. Eckert & Ziegler
10.3.4. GE Healthcare
10.3.5. IBA Radiopharma Solutions
10.3.6. Lantheus Holdings Inc.
10.3.7. Mallinckrodt Plc
10.3.8. Nordion Inc.
10.3.9. Positron Corporation
10.3.10. Siemens Healthineers
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.1.6. Research Assumption

List of Tables
TABLE 1. LIST OF SECONDARY SOURCES, USED IN THE STUDY OF RADIOPHARMACEUTICALS MARKET
TABLE 2. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF RADIOPHARMACEUTICALS MARKET
TABLE 3. RADIOPHARMACEUTICALS MARKET, REPORT SCOPE
TABLE 4. YEARS CONSIDERED FOR THE STUDY
TABLE 5. EXCHANGE RATES CONSIDERED
TABLE 6. RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY REGION 2016-2026 (USD BILLION)
TABLE 7. RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY RADIOISOTOPE 2016-2026 (USD BILLION)
TABLE 8. RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SOURCE 2016-2026 (USD BILLION)
TABLE 9. RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY APPLICATION 2016-2026 (USD BILLION)
TABLE 10. RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY END-USER 2016-2026 (USD BILLION)
TABLE 11. RADIOPHARMACEUTICALS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 12. RADIOPHARMACEUTICALS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 13. RADIOPHARMACEUTICALS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 14. RADIOPHARMACEUTICALS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 15. RADIOPHARMACEUTICALS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 16. RADIOPHARMACEUTICALS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 17. RADIOPHARMACEUTICALS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 18. RADIOPHARMACEUTICALS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 19. RADIOPHARMACEUTICALS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 20. RADIOPHARMACEUTICALS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 21. RADIOPHARMACEUTICALS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 22. RADIOPHARMACEUTICALS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 23. RADIOPHARMACEUTICALS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 24. RADIOPHARMACEUTICALS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 25. RADIOPHARMACEUTICALS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 26. RADIOPHARMACEUTICALS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 27. RADIOPHARMACEUTICALS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 28. RADIOPHARMACEUTICALS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 29. RADIOPHARMACEUTICALS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 30. RADIOPHARMACEUTICALS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 31. RADIOPHARMACEUTICALS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 32. RADIOPHARMACEUTICALS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 33. RADIOPHARMACEUTICALS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 34. RADIOPHARMACEUTICALS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 35. RADIOPHARMACEUTICALS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 36. RADIOPHARMACEUTICALS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 37. RADIOPHARMACEUTICALS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 38. RADIOPHARMACEUTICALS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 39. RADIOPHARMACEUTICALS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 40. RADIOPHARMACEUTICALS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 41. RADIOPHARMACEUTICALS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 42. RADIOPHARMACEUTICALS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 43. RADIOPHARMACEUTICALS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 44. RADIOPHARMACEUTICALS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 45. RADIOPHARMACEUTICALS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 46. RADIOPHARMACEUTICALS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 47. U.S. RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 48. U.S. RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 49. U.S. RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 50. U.S. RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 51. U.S. RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 52. CANADA RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 53. CANADA RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 54. CANADA RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 55. CANADA RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 56. CANADA RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 57. UK RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 58. UK RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 59. UK RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 60. UK RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 61. UK RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 62. GERMANY RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 63. GERMANY RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 64. GERMANY RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 65. GERMANY RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 66. GERMANY RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 67. ROE RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 68. ROE RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 69. ROE RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 70. ROE RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 71. ROE RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 72. CHINA RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 73. CHINA RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 74. CHINA RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 75. CHINA RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 76. CHINA RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 77. INDIA RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 78. INDIA RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 79. INDIA RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 80. INDIA RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 81. INDIA RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 82. JAPAN RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 83. JAPAN RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 84. JAPAN RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 85. JAPAN RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 86. JAPAN RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 87. ROAPAC RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 88. ROAPAC RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 89. ROAPAC RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 90. ROAPAC RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 91. ROAPAC RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 92. BRAZIL RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 93. BRAZIL RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 94. BRAZIL RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 95. BRAZIL RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 96. BRAZIL RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 97. MEXICO RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 98. MEXICO RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 99. MEXICO RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 100. MEXICO RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 101. MEXICO RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 102. ROLA RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 103. ROLA RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 104. ROLA RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 105. ROLA RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 106. ROLA RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 107. ROW RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 108. ROW RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 109. ROW RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 110. ROW RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 111. ROW RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

List of Figures
FIG 1. RADIOPHARMACEUTICALS MARKET, RESEARCH METHODOLOGY
FIG 2. RADIOPHARMACEUTICALS MARKET, MARKET ESTIMATION TECHNIQUES
FIG 3. GLOBAL MARKET SIZE ESTIMATES & FORECAST METHODS
FIG 4. RADIOPHARMACEUTICALS MARKET, KEY TRENDS 2017
FIG 5. RADIOPHARMACEUTICALS MARKET, GROWTH PROSPECTS 2018-2026
FIG 6. RADIOPHARMACEUTICALS MARKET, PORTERS 5 FORCE MODEL
FIG 7. RADIOPHARMACEUTICALS MARKET, PEST ANALYSIS
FIG 8. RADIOPHARMACEUTICALS MARKET, VALUE CHAIN ANALYSIS
FIG 9. RADIOPHARMACEUTICALS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 10. RADIOPHARMACEUTICALS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 11. RADIOPHARMACEUTICALS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 12. RADIOPHARMACEUTICALS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 13. RADIOPHARMACEUTICALS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 14. RADIOPHARMACEUTICALS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 15. RADIOPHARMACEUTICALS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 16. RADIOPHARMACEUTICALS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 17. RADIOPHARMACEUTICALS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 18. RADIOPHARMACEUTICALS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 19. RADIOPHARMACEUTICALS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 20. RADIOPHARMACEUTICALS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 21. RADIOPHARMACEUTICALS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 22. RADIOPHARMACEUTICALS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 23. RADIOPHARMACEUTICALS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 24. RADIOPHARMACEUTICALS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 25. RADIOPHARMACEUTICALS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 26. RADIOPHARMACEUTICALS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 27. RADIOPHARMACEUTICALS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 28. RADIOPHARMACEUTICALS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 29. RADIOPHARMACEUTICALS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 30. RADIOPHARMACEUTICALS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 31. RADIOPHARMACEUTICALS MARKET, REGIONAL SNAPSHOT 2016 & 2026
FIG 32. NORTH AMERICA RADIOPHARMACEUTICALS MARKET 2016 & 2026 (USD BILLON)
FIG 33. EUROPE RADIOPHARMACEUTICALS MARKET 2016 & 2026 (USD BILLON)
FIG 34. ASIA PACIFIC RADIOPHARMACEUTICALS MARKET 2016 & 2026 (USD BILLON)
FIG 35. LATIN AMERICA RADIOPHARMACEUTICALS MARKET 2016 & 2026 (USD BILLON)
FIG 36. RADIOPHARMACEUTICALS MARKET, COMPANY MARKET SHARE ANALYSIS (2017)


★調査レポート[放射性医薬品の世界市場:放射性同位体別(テクネチウム-99、ガリウム-67、ヨウ素-123、18F、ルビジウム-82、イットリウム-90、ルテチウム-177)、由来別(原子炉、サイクロトロン)、用途別(心臓病学、消化器病学、腫瘍学、腎臓学、神経学、免疫学、その他)、エンドユーザー別(病院、外来手術センター、診断センター、その他)、地域別予測] (コード:BZW9JN065)販売に関する免責事項を必ずご確認ください。
★調査レポート[放射性医薬品の世界市場:放射性同位体別(テクネチウム-99、ガリウム-67、ヨウ素-123、18F、ルビジウム-82、イットリウム-90、ルテチウム-177)、由来別(原子炉、サイクロトロン)、用途別(心臓病学、消化器病学、腫瘍学、腎臓学、神経学、免疫学、その他)、エンドユーザー別(病院、外来手術センター、診断センター、その他)、地域別予測]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆